According to Redhill Biopharma's latest financial reports the company's current revenue (TTM ) is S$48.43 Million. In 2022 the company made a revenue of S$82.84 Million a decrease over the revenue in the year 2021 that were of S$0.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.